Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Michael Yu

2PUBLICATIONS

2CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacology and therapeutics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jul 09, 2021

PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity.

Haiping Jiang, Haiqing Ni, Pan Zhang

|Aug 13, 2019

Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit.

Jie Wang, Keke Fei, Hua Jing

Pageof 1

Frequent Collaborators

2 joint publications

Zhihai Wu

2 joint publications

Weiwei Wu

Frequent Collaborators

2 joint publications

Zhihai Wu

2 joint publications

Weiwei Wu

Top Related Videos

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on : Jul 07, 2023

See more related videos

Top Related Videos

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on : Jul 07, 2023

See more related videos